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Judging quality of current septic shock
definitions and criteria
Manu Shankar-Hari1,2*, Guido Bertolini3, Frank M. Brunkhorst4, Rinaldo Bellomo5, Djillali Annane6,
Clifford S. Deutschman7,8 and Mervyn Singer9
Abstract
Septic shock definitions are being revisited. We assess
the feasibility, reliability, and validity characteristics of
the current definitions and criteria of septic shock.
Septic shock is conceptualised as cardiovascular
dysfunction, tissue perfusion and cellular abnormalities
caused by infection. Currently, for feasibility, septic
shock is identified at the bedside by using either
hypotension or a proxy for tissue perfusion/cellular
abnormalities (e.g., hyperlactatemia). We propose that
concurrent presence of cardiovascular dysfunction and
perfusion/cellular abnormalities could improve validity
of septic shock diagnosis, as we are more likely to
identify a patient population with all elements of
the illness concept. This epidemiological refinement
should not affect clinical care and may aid study
design to identify illness-specific biomarkers and
interventions.
Introduction
The illness concept, with its description (definition), clin-
ical symptoms, signs and laboratory tests (criteria), and
consequences (outcome), inform clinical reasoning and
diagnosis. Diagnostic certainty is important for patients,
clinicians and researchers as it helps to identify risk fac-
tors, select optimal treatment, devise new therapies, and
prognosticate. In this context, septic shock is a clinical
syndrome with protean clinical manifestations and bio-
chemical abnormalities but with no universally accepted
gold standard for diagnosis [1]. In the absence of a gold
standard test, the clinician-determined probability of the
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illness, the definition and the corresponding criteria are
fundamental to diagnosing syndromes. After outlining the
septic shock illness concept, this article evaluates how
bedside operationalization of current definitions of
septic shock definitions and their corresponding clin-
ical criteria influence the validity, reliability, and feasibil-
ity attributes [2].
Illness concept
Infection triggers a series of host responses, dysregu-
lation of which results in organ dysfunction (sepsis)
[3–5]. Septic shock, the most severe form of sepsis, is
highly complex, with concurrent myocardial, vascular
(macro- and micro-), tissue perfusion and cellular
level abnormalities. Myocardial abnormalities include
both cardiomyocyte injury [4] and structural myocardial
dysfunction [6, 7]. Vascular abnormalities affect the endo-
thelium, sub-endothelial tissues, microcirculation and
vasomotor tone. These alter systemic vascular resistance,
increase endothelial permeability, impair tissue oxygen
delivery (tissue hypoxia) and utilization (cellular dysoxia),
and modify cellular metabolism (Fig. 1) [8–15].
Current definitions and criteria for septic shock
The 1992 and 2001 Sepsis Consensus Conference defini-
tions [16, 17] and the definition used by the Surviving
Sepsis Campaign (SSC) guidelines [18] currently provide
the most-cited case definitions and criteria for making a
diagnosis of septic shock. Yet all differ for both definition
and criteria (e.g., use of different cutoffs for hypotension)
and variable use of markers of impaired tissue perfusion
(e.g., raised lactate, base deficit). There is also an implicit
reliance upon clinician-driven interventions such as fluid
therapy or inotropes. Thus, there are potentially varying
combinations of clinical criteria and differences in the
interventional targets used to diagnose septic shock. This
heterogeneity highlights the limitations of current opera-
tionalization methods [19–21].
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Judging quality attributes of septic shock
definitions and criteria
Validity
Validity is the ability to capture what the investigator
truly seeks to measure. Validity assessments can be either
qualitative (face validity, content validity) or quantitative
(criterion validity, construct validity).
Face validity
“Face validity” refers to whether patients identified by
the criteria appear to match the illness concept at face
value. At present, hypotension is a core element of the
criteria identifying septic shock. However, the presence
of hypotension in the context of infection does not ne-
cessarily define septic shock. Hypotension in an infected
patient could be related to pre-illness medications (e.g.,
antihypertensive), comorbidities (e.g., heart failure) or
concurrent interventions (e.g., sedatives) or a combination
of these. In other words, we remain uncertain whether
hypotension as the only criterion truly represents septic
shock, especially when used without caveats to address
potential confounders (e.g., medications or heart failure).
Furthermore, we cannot quantify this uncertainty, as there
is no gold standard test for septic shock.
Content validity
Content validity assesses whether the clinical criteria en-
compass all components of the illness. For septic shock,
these components are cardiovascular dysfunction, hypo-
perfusion and cellular abnormalities. We highlighted
above that hypotension alone is an incomplete proxy for
cardiovascular dysfunction to define septic shock. Equally,
imperfect proxies of tissue hypoperfusion such as base
deficit, confusion or oliguria are inadequate in isolation to
define septic shock [16]. Similarly, we currently lack a reli-
able proxy to measure the complex cellular abnormalities
that occur in septic shock. Hyperlactatemia is often used
as a proxy; however, this is usually found in all types of
shock [8] and the serum level is variably related to mul-
tiple confounders, including the rate of tissue utilization
(lactate clearance), accelerated β-adrenergic-driven aer-
obic glycolysis, liver dysfunction and co-existing anaerobic
glycolysis [11, 22–25].
Given the lack of a gold standard diagnostic test for
septic shock, the performance characteristics of these
variables (sensitivity, specificity, and predictive values)
could be based on prognosis (e.g., short-term mortality),
with or without a clinical reclassification risk assessment
or blinded clinician adjudication [26]. If we alter the
existing clinical criteria, the reclassification risk refers to
the proportion of patients reclassified into new risk-of-
death categories [26]. Levy et al., using the SSC dataset,
gave a simple descriptive demonstration of this concept
by using lactate as an additional marker for septic shock
in a cohort of patients with an overall mortality of 38.4 %
[27]. The authors reported categories of shock as lactate
of more than 4 mmol/l only (29.9 % mortality), vasopres-
sor use only (36.7 % mortality), or a combination of lactate
of more than 4 mmol/l plus vasopressor use (46.1 % mor-
tality). A similar exercise conducted on data collected
from English intensive care units (ICUs) reported mortal-
ity rates of 26.2 % for patients with an isolated lactate level
Fig. 1 Simplified overview of septic shock biology
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of more than 4 mmol/l, 31.4 % for refractory hypotension
only, and 55.5 % for the combination [28]. Kaukonen et al.
recently evaluated the performance characteristics of the
four systemic inflammatory response syndrome (SIRS)
criteria in identifying sepsis [29]. They highlighted that
12 % of patients admitted to ICUs with organ dysfunction
consequent to presumed infection were SIRS-negative
(i.e., had fewer than two criteria of SIRS). Thus, if sepsis
criteria are developed without requiring SIRS variables,
different risk categories within patient populations may be
identified (i.e., reclassification).
While cardiovascular organ dysfunction has long been
central to the definition of septic shock, the criteria used
to identify it remain variable. Levy et al. [17] specified the
use of either Sepsis Organ Failure Assessment (SOFA) or
multiple organ dysfunction score (MODS) to quantify
organ dysfunction in patients with severe sepsis [30, 31].
However, these two scoring systems differ, particularly in
terms of cardiovascular dysfunction criteria. The SOFA
score uses both mean arterial pressure and the dose of
vasoactive drugs being administered. By contrast, the
MODS is solely physiology-based, using a pressure-
adjusted heart rate parameter derived from heart rate,
central venous pressure and mean arterial pressure to re-
flect fluid-unresponsive hypotension. Under the MODS
scoring system, organ dysfunction is a continuum with no
category differentiating dysfunction from failure [30–32].
Cardiovascular dysfunction is quantified by a continuous
variable derived by using regression analyses to define the
variables and their weights. In contrast, SOFA, which was
developed by using expert opinion, views cardiovascular
dysfunction as occurring in discrete steps, with a score of
1 or 2 being coded as organ “dysfunction” and 3 or 4
coded as organ “failure”. Thus, the cutoffs and relative
weights of variables within these scores are unlikely to
stratify cardiovascular dysfunction similarly [33].
Criterion and construct validity
Criterion validity encompasses both concurrent and pre-
dictive validities. Concurrent validity refers to the ability
of the definition and criteria to discriminate groups,
whereas predictive validity is the ability to predict (future)
outcomes. A closely related concept is construct validity;
this refers to an assessment of how well the definitions are
converted into measurable criteria to identify septic shock
in clinical practice.
There are many examples in the literature of poor
criterion validity for current definitions and criteria of
septic shock. For example, a cohort study of nearly 8000
patients defined by the 1992 criteria as having septic
shock [16] reported an overall crude hospital mortality
of 52.4 % [20]. However, mortality ranged from 21.1 to
84.5 % when stratified on anatomical site of infection,
and this variation persisted despite adjustments for
confounders such as age, comorbidities and organism
type. Given that cardiovascular dysfunction is the core cri-
terion used for diagnosis, the predictive validity of current
definitions of septic shock is weak, being heavily dependent
on how it is operationalized at the bedside [19].
Outcome is also affected by how the individual com-
ponents of septic shock (cardiovascular dysfunction, hy-
poperfusion and cellular abnormalities) are determined.
Mortality in a single dataset varied from 45 to 60 %
depending on what diagnostic criteria were applied [34].
Similarly, hospital mortality rates in septic shock pa-
tients admitted to ICUs in Australia and New Zealand
(171 ICUs; n = 6757) (ANZICS data, R. Bellomo, per-
sonal communication) and Italy (221 ICUs; n = 4959)
(GiViTI data, Italian ICU registry; Margherita project, G.
Bertolini, personal communication) during 2012 were
reported as 22 and 57.9 %, respectively. The Australasian
case definition was predicated upon an APACHE III
(Acute Physiology and Chronic Health Evaluation III)
diagnosis coding of infection plus recording of either a
decrease in mean blood pressure of less than 65 mmHg
or systolic blood pressure of less than 90 mmHg at any
time within the first 24 h of admission. In contrast, the
Italian criteria used those provided by the 2001 Consen-
sus definitions [17]. Even when data were extracted from
representative national datasets by using the International
Classification of Diseases coding system, the hospital mor-
tality using the septic shock code was much higher in
Germany (60.5 % in 2011) [35] than in the USA (42.1 %
between 2004 and 2009) [21]. Are outcomes in Germany
much worse, or do the differences merely reflect coding
practices or variable patient pathways (e.g., transfer to
post-acute care hospitals) [36]?
Secular trends in septic shock outcomes are depicted
in Fig. 2. Among other explanations [37], this improving
trend in mortality may also represent an enhanced de-
tection of a less severe “septic shock” population using
hypotension alone as a criterion (i.e., stage migration, or
the Will Rogers phenomenon [38]).
Reliability
Reliability refers to agreement between observers and by
the same observer during repeated measurements (i.e.,
consistency and reproducibility). With septic shock, some
measurements, such as blood pressure and lactate levels,
are likely to have reasonably high inter-observer, intra-
observer and intra-subject reliability subject to certain ca-
veats and exclusion of methodological errors. On the
other hand, adequacy of fluid resuscitation and initiation
of vasopressor therapy are far more subjective because of
a lack of consensus on triggers and end-points. Potentially,
we can test the reliability attributes of these variables (e.g.,
consistency within and between observers) by using test-
retest reliability and the related kappa statistic.
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Feasibility
Feasibility is a composite concept that depends on the
purpose of the diagnosis; it is a compromise between
validity and reliability [2]. For a high-mortality condition
such as septic shock, ease of detection is key. The SSC
guidelines have increased feasibility by emphasizing car-
diovascular dysfunction criteria for the diagnosis of sep-
tic shock [18]. However, relaxing diagnostic criteria will
almost certainly increase the rate of false-positive diag-
noses. Conversely, if the complexity and number of cri-
teria to be met for diagnosis are increased to improve
validity, then feasibility will almost certainly be reduced.
For example, the incidence of septic shock was halved
from 9.1 to 4.4 % when liberal criteria (i.e., refractory
hypotension) were replaced with restrictive criteria (i.e.,
refractory hypotension with non-cardiovascular dysfunc-
tion) [34].
How could we address these challenges?
The above discussion highlights variability in the criteria
used to identify septic shock in published research. The
European Society of Intensive Care Medicine-Society of
Critical Care Medicine (ESICM-SCCM) Task Force on
new definitions of sepsis is currently undertaking a sys-
tematic review of the literature to explore how these
septic shock definitions and criteria are operationalized.
Observational studies reporting the incidence and out-
comes of septic shock are ideal target publications as ran-
domized controlled trials often have trial-specific criteria.
The second step in this process is to generate agreement
on the updated illness concept which should reflect all
three domains of biology (i.e., cardiovascular dysfunction,
cellular abnormalities and evidence of impaired tissue per-
fusion). Based on this illness concept and by applying the
principle of parsimony, the minimum number of bedside
variables that have face and content validity could be
determined. Inter-observer reliability of septic shock case
detection could be improved by using a single validated
criterion for cardiovascular dysfunction (e.g., need for
vasopressor therapy to maintain target blood pressure)
and a proxy for likely cellular and impaired tissue per-
fusion abnormality (e.g., lactate). These steps could be
achieved with qualitative research methods, such as a
Delphi process [39]. An important research question
in this context is whether septic shock illness criteria
should have predictive validity [19]. If we believe that
septic shock is the most severe form of sepsis, then
an argument could be made for having predictive validity
as a characteristic of any updated septic shock criteria.
This research question could be addressed by developing
a parsimonious model using combinations and cutoffs of
the variables for outcomes such as short-term mortality.
Conclusions
Septic shock conceptually comprises an illness with new
onset or worsening cardiovascular dysfunction, impaired
tissue perfusion and cellular abnormalities caused by in-
fection. Individually, none of these abnormalities truly
reflects the complex illness concept but they may do so
in combination, potentially improving the validity and
reliability of a diagnosis of septic shock. As there are no
specific treatments for this condition, this epidemiological
refinement will not affect clinical care and may aid the de-
sign of studies that can identify illness-specific biomarkers
and interventions.
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Fig. 2 Secular trends in septic shock mortality. Cub-REA Data were
provided by Philippe Aegerter, Bertrand Guidet and D. Annane for
the Cub-REA network, which used International Classification of
Diseases (ICD)-9 and ICD-10 codes and the Bone definition [16].
GiViTI data were provided by Bertolini et al. using 2001 Consensus
Definitions [16, 17]. ANZICS data, provided by Bellomo et al. (personal
communications), used hypotension as the definition for septic shock.
Brunkhorst et al. (personal communications) provided German data for
2011, using ICD codes for the diagnosis of septic shock
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